[1] |
Joshi P, Dutta S, Chaturvedi P, et al. Head and neck cancers in developing countries[J]. Rambam Maimonides Med J, 2014, 5(2): e0009.
|
[2] |
Chaturvedi AK, Anderson WF, Lortet-Tieulent J, et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers[J]. J Clin Oncol, 2013, 31(36): 4550-4559.
doi: 10.1200/JCO.2013.50.3870
pmid: 24248688
|
[3] |
Kerawala C, Roques T, Jeannon JP, et al. Oral cavity and lip cancer: United Kingdom National Multidisciplinary Guidelines[J]. J Laryngol Otol, 2016, 130(S2): S83-S89.
|
[4] |
钟来平. 口腔鳞状细胞癌临床诊治的规范化和个体化: 机遇与挑战[J]. 华西口腔医学杂志, 2020, 38(5): 484-488.
|
[5] |
Seyedmajidi M, Sohanian S, Abbaszadeh H, et al. Astrocyte elevated gene 1 (AEG-1): A promising candidate for molecular targeted therapy in oral squamous cell carcinomas[J]. Asian Pac J Cancer Prev, 2017, 18(12): 3301-3305.
|
[6] |
Sweeney C, Bracarda S, Sternberg CN, et al. ipatasertib plus abiraterone and prednisolone in metastatic castration-resistant prostate cancer (IPATential150): A multicentre, randomised, double-blind, phase 3 trial[J]. Lancet, 2021, 398(10295): 131-142.
doi: 10.1016/S0140-6736(21)00580-8
pmid: 34246347
|
[7] |
Laterza MM, Ciaramella V, Facchini BA, et al. Enhanced antitumor effect of trastuzumab and duligotuzumab or ipatasertib combination in HER-2 positive gastric cancer cells[J]. Cancers, 2021, 13(10): 2339.
|
[8] |
Komatsu M, Waguri S, Ueno T, et al. Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice[J]. J Cell Biol, 2005, 169(3): 425-434.
doi: 10.1083/jcb.200412022
pmid: 15866887
|
[9] |
Anding AL, Baehrecke EH. Cleaning house: Selective autophagy of organelles[J]. Dev Cell, 2017, 41(1): 10-22.
doi: S1534-5807(17)30085-0
pmid: 28399394
|
[10] |
Wang K, Klionsky DJ. Mitochondria removal by autophagy[J]. Autophagy, 2011, 7(3): 297-300.
doi: 10.4161/auto.7.3.14502
pmid: 21252623
|
[11] |
Aqbi HF, Tyutyunyk-Massey L, Keim RC, et al. Autophagy-deficient breast cancer shows early tumor recurrence and escape from dormancy[J]. Oncotarget, 2018, 9(31): 22113-22122.
doi: 10.18632/oncotarget.25197
pmid: 29774126
|
[12] |
Hung CM, Lombardo PS, Malik N, et al. AMPK/ULK1-mediated phosphorylation of Parkin ACT domain mediates an early step in mitophagy[J]. Sci Adv, 2021, 7(15): eabg4544.
|
[13] |
Yeganeh B, Lee J, Ermini L, et al. Autophagy is required for lung development and morphogenesis[J]. J Clin Invest, 2019, 129(7): 2904-2919.
doi: 10.1172/JCI127307
pmid: 31162135
|
[14] |
Chou TC. Drug combination studies and their synergy quantification using the Chou-Talalay method[J]. Cancer Res, 2010, 70(2): 440-446.
|
[15] |
Sawada S, Mese H, Sasaki A, et al. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line[J]. Cancer Chemother Pharmacol, 2003, 51(6): 505-511.
|
[16] |
Levy JMM, Towers CG, Thorburn A. Targeting autophagy in cancer[J]. Nat Rev Cancer, 2017, 17(9): 528-542.
doi: 10.1038/nrc.2017.53
pmid: 28751651
|
[17] |
de Bono JS, de Giorgi U, Rodrigues DN, et al. Randomized phase Ⅱ study evaluating Akt blockade with ipatasertib, in combination with abiraterone, in patients with metastatic prostate cancer with and without PTEN loss[J]. Clin Cancer Res, 2019, 25(3): 928-936.
|
[18] |
Yu L, Liu ZS, Qiu L, et al. ipatasertib sensitizes colon cancer cells to TRAIL-induced apoptosis through ROS-mediated caspase activation[J]. Biochem Biophys Res Commun, 2019, 519(4): 812-818.
|